Despite significant therapeutic improvements, congestive heart failure (CHF) patients still
have a poor prognosis. Currently, 5-year survival rates are only 35-50%. There is an
accumulating body of evidence from prospective cohort studies that low circulating
25-hydroxyvitamin D is an independent predictor of all-cause and cardiovascular mortality,
respectively. Vitamin D deficiency is prevalent among CHF patients. We hypothesize that
vitamin D may improve survival in CHF patients. We therefore aimed to investigate whether
vitamin D supplementation reduces mortality and increases event-free survival in end-stage
CHF patients.
Phase:
Phase 4
Details
Lead Sponsor:
Heart and Diabetes Center North-Rhine Westfalia
Treatments:
Ergocalciferols Pharmaceutical Solutions Vitamin D Vitamins